Movement Alert|Guardant Health Falls 5.02% in Regular Trading, Trading at $154.86

Market Focus
07/17

On July 17, Guardant Health fell 5.02% in regular trading, trading at $154.86 USD/share, with Turnover of $3.59 billion.

Within the Health Care Services sector where Guardant Health belongs, performance was mixed. Among individual stocks, Quest Diagnostics up 3.79%, CVS Health up 0.55%, BrightSpring Health Services down 0.12%, THE CIGNA GROUP down 5.05%, Hims & Hers Health down 9.46%.

Guardant Health is a leading precision oncology company that provides blood and tissue tests, data sets, and analytics. Its product portfolio includes Guardant360, Guardant360 CDx, Shield Test, and Guardant Reveal, covering advanced-stage cancer genomic profiling, early cancer screening, and therapy response monitoring. The company's next earnings report is scheduled for July 30 after market close.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10